MX2025005591A - Cristal de derivado de piperazina sustituido y metodo de preparacion del mismo - Google Patents
Cristal de derivado de piperazina sustituido y metodo de preparacion del mismoInfo
- Publication number
- MX2025005591A MX2025005591A MX2025005591A MX2025005591A MX2025005591A MX 2025005591 A MX2025005591 A MX 2025005591A MX 2025005591 A MX2025005591 A MX 2025005591A MX 2025005591 A MX2025005591 A MX 2025005591A MX 2025005591 A MX2025005591 A MX 2025005591A
- Authority
- MX
- Mexico
- Prior art keywords
- preparation
- crystal
- method therefor
- piperazine derivative
- substituted piperazine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211417721 | 2022-11-14 | ||
| PCT/CN2023/131627 WO2024104354A1 (zh) | 2022-11-14 | 2023-11-14 | 一种取代的哌嗪衍生物的晶体及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2025005591A true MX2025005591A (es) | 2025-06-02 |
Family
ID=90997576
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2025005591A MX2025005591A (es) | 2022-11-14 | 2025-05-13 | Cristal de derivado de piperazina sustituido y metodo de preparacion del mismo |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250270223A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4620958A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7866687B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20250086779A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118027039A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023381502A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2025005591A (cg-RX-API-DMAC7.html) |
| TW (1) | TWI879228B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2024104354A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL326495A (en) * | 2023-08-17 | 2026-04-01 | Kangbaida Sichuan Biotechnology Co Ltd | Pharmaceutical preparation of piperazine derivative, preparation method therefor, and use thereof |
| WO2025209574A1 (zh) * | 2024-04-03 | 2025-10-09 | 康百达(四川)生物医药科技有限公司 | 用于预防或治疗肿瘤的parp7抑制剂 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112020022006A2 (pt) * | 2018-04-30 | 2021-01-26 | Ribon Therapeutics Inc. | piridazinonas como inibidores de parp7 |
| WO2020223229A1 (en) * | 2019-04-29 | 2020-11-05 | Ribon Therapeutics, Inc. | Solid forms of a parp7 inhibitor |
| CN112745312B (zh) * | 2019-10-30 | 2022-08-30 | 沈阳中化农药化工研发有限公司 | 哒嗪酮异恶唑甲醚类化合物及其应用 |
| WO2021087018A1 (en) * | 2019-10-30 | 2021-05-06 | Ribon Therapeutics, Inc. | Pyridazinones as parp7 inhibitors |
| CN116157396B (zh) * | 2020-11-27 | 2025-07-18 | 康百达(四川)生物医药科技有限公司 | 哒嗪酮衍生物及其在医药上的应用 |
| WO2022156708A1 (en) * | 2021-01-20 | 2022-07-28 | Jacobio Pharmaceuticals Co., Ltd. | Parp7 enzyme inhibitor |
| CN117279917A (zh) * | 2021-05-21 | 2023-12-22 | 成都百裕制药股份有限公司 | 哌嗪衍生物及其在医药上的应用 |
-
2023
- 2023-11-14 TW TW112143895A patent/TWI879228B/zh active
- 2023-11-14 WO PCT/CN2023/131627 patent/WO2024104354A1/zh not_active Ceased
- 2023-11-14 CN CN202311526331.4A patent/CN118027039A/zh active Pending
- 2023-11-14 JP JP2025525056A patent/JP7866687B2/ja active Active
- 2023-11-14 EP EP23890787.7A patent/EP4620958A4/en active Pending
- 2023-11-14 AU AU2023381502A patent/AU2023381502A1/en active Pending
- 2023-11-14 KR KR1020257016149A patent/KR20250086779A/ko active Pending
-
2025
- 2025-05-13 MX MX2025005591A patent/MX2025005591A/es unknown
- 2025-05-13 US US19/207,109 patent/US20250270223A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP7866687B2 (ja) | 2026-05-27 |
| EP4620958A1 (en) | 2025-09-24 |
| TWI879228B (zh) | 2025-04-01 |
| JP2025536416A (ja) | 2025-11-05 |
| AU2023381502A1 (en) | 2025-05-15 |
| US20250270223A1 (en) | 2025-08-28 |
| EP4620958A4 (en) | 2026-08-05 |
| KR20250086779A (ko) | 2025-06-13 |
| TW202426452A (zh) | 2024-07-01 |
| CN118027039A (zh) | 2024-05-14 |
| WO2024104354A1 (zh) | 2024-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12022552395A1 (en) | Pyrimidoheterocyclic compounds and application thereof | |
| ZA202500635B (en) | Piperazine bridge-substituted heterocyclic pyrimidine compound | |
| ZA202406389B (en) | Benzopyrimidine compounds and use thereof | |
| MX2023012054A (es) | Inhibidor derivado heterociclico y metodo de preparacion y su aplicacion. | |
| MX2025003665A (es) | Derivados macrociclicos y las aplicaciones de estos | |
| MX2024015714A (es) | Compuesto de pirimidopirano sustituido heterocíclico y uso de este | |
| ZA202403530B (en) | Method for preparing l-glufosinate | |
| ZA202104112B (en) | 15-pgdh inhibitor | |
| CR20230496A (es) | Compuestos heterocíclicos | |
| WO2022251561A3 (en) | Spiroindolinone compounds as kv1.3 potassium shaker channel blockers | |
| MX2023000970A (es) | Metodo de preparacion de aminofuranos. | |
| MX2025001749A (es) | Compuesto como inhibidor del canal de sodio dependiente del voltaje | |
| WO2023150592A3 (en) | N3-substituted uracil compounds as trpa1 inhibitors | |
| MX2025006444A (es) | Proceso para la sintesis de moduladores de tetrahidrofurano sustituidos de los canales de sodio | |
| CR20230465A (es) | Compuestos heterocíclicos de arilo como bloqueadores del canal agitador de potasio kv1.3 | |
| EP4410989A3 (en) | Method for producing heterocyclidene acetamide derivatives | |
| ZA202402459B (en) | Compounds for regulating trained immunity, and their methods of use | |
| MX2025002355A (es) | Compuestos de triazina y usos de los mismos | |
| MX2025009371A (es) | Forma cristalina de derivado de sulfonamida y metodo de preparacion para ello | |
| MX2023001418A (es) | Forma sólida de compuesto. | |
| WO2022057836A8 (zh) | 苯并脲环衍生物及其制备方法和应用 | |
| TW202617700A (zh) | 用於製備4-胺基-呋喃之方法 | |
| MX2025004783A (es) | Forma cristalina de un derivado de imidazopiracina, metodo de preparacion de la misma y uso de la misma | |
| PH12021552787A1 (en) | Tetracyclic compounds as cdc7 inhibitors | |
| PH12021552225A1 (en) | Crystal of heterocyclic amide compound and method for producing same |